Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1α), and transforming growth factors β1 (TGFβ1) and β3 (TGFβ3) in gestational trophoblastic disease

Pathology Research and Practice

Volumn 206, Issue 1, 2010, Pages 19-23

  Bolat, F ^a   Haberal, N ^a   Tunali, N ^b   Aslan, E ^a   Bal, N ^a   Tuncer, I ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Gestational trophoblastic disease; Hypoxia inducible factor 1 alpha (HIF 1 ); Transforming growth factor 1 and 3 (TGF 1 and 3); Vascular endothelial growth factor (VEGF)

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOGENESIS; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOGENESIS; PROTEIN EXPRESSION; SPONTANEOUS ABORTION; TROPHOBLASTIC TUMOR;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHORIOCARCINOMA; FEMALE; HUMANS; HYDATIDIFORM MOLE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREGNANCY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UTERINE NEOPLASMS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73649093738     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.07.017     Document Type: Article

References (24)

1. Athanassiades A., Hamilton G.S., and Lala P.K. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol. Reprod. 59 3 (1998) 643-654
2. Bae S.N., and Kim S.J. Telomerase activity in complete hydatidiform mole. Am. J. Obstet. Gynecol. 180 2 Pt 1 (1999) 328-333
3. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., and Lye S.J. Inhibition of TGF-beta3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J. Clin. Invest. 103 (1999) 1641-1650
4. Cheung A.N., Zhang D.K., Liu Y., Ngan H.Y., Shen D.H., and Tsao S.W. Telomerase activity in gestational trophoblastic disease. J. Clin. Pathol. 52 8 (1999) 588-592
5. Hamilton G.S., Lysiak J.J., Han V.K., and Lala V.K. Autocrine paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF) II and IGF binding protein (IGFBP). J. Exp. Cell. Res. 244 (1998) 147-156
6. Iwase K., Okamoto T., Nui R., and Mizutani S. Expression of nm23-H1 in hydatidiform mole and its relationship with the development of postmolar disease. Gynecol. Obstet. Invest. 51 4 (2001) 228-232
7. Kale A., Soylemez F., and Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am. J. Obstet. Gynecol. 184 4 (2001) 567-574
8. Kauma S.W., Bae-Jump V., and Walsh S.W. Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia. J. Clin. Endocrinol. Metab. 84 11 (1999) 4092-4096
9. Nishi H., Nakada T., Hokamura M., et al. Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast. Endocrinology 145 9 (2004) 4113-4118
10. Nygan H.S.Y. The practibility of FIGO 2000 staging for gestational trophoblastic neoplasia. Int. J. Gynecol. Cancer 14 (2004) 202-205
11. Okamoto T., Niu R., Mizutani S., and Yamada S. Levels of placenta growth factor in gestational trophoblastic diseases. Am. J. Obstet. Gynecol. 188 1 (2003) 135-140
12. Olvera M., Haris S., Amezcua C.A., et al. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cylin E, p27 (kip1), and Ki-67 in normal placenta and gestational trophoblastic disease. Mod. Pathol. 14 10 (2001) 1036-1042
13. Pang Z.J., and Xing F.Q. Expression of transforming growth factor-beta and insulin-like growth factor in molar and placental tissues. Arch. Gynecol. Obstet. 269 1 (2003) 1-4
14. Qian D., Lin H.Y., Wang H.M., et al. Involvement of ERK1/2 pathway in TGF-beta1-induced VEGF secretion in normal human cytotrophoblast cells. Mol. Reprod. Dev. 68 2 (2004) 198-204
15. Rama S., Suresh Y., and Rao A.J. Regulation of telomerase during human placental differentiation: a role for TGF-β1. Mol. Cell. Endocrinol. 182 2 (2001) 233-248
16. Roth I I., and Fisher S.J. IL-10 is an autocrine inhibitor of human placental trophoblast MMP-9 production and invasion. Dev. Biol. 205 (1999) 194-204
17. Shaarawy M., El-Mallah S.Y., and Sheiba M. Angiogenin and gestational trophoblastic tumors, a promising prognostic marker. Clin. Chem. Lab. Med. 41 3 (2003) 306-310
18. Shih I.M., and Kurman R.J. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. Verh. Dtsch. Ges. Pathol. 81 (1997) 266-272
19. Smith H.O. Gestational trophoblastic disease epidemiology and trends. Clin. Obstet. Gynecol. 46 3 (2003) 541-556
20. Szulman A.E., and Surti U. The syndromes hydatidiform mole I. Cytogenetic and morphologic correlations,. Am. J. Obstet. Gynecol. 131 (1978) 665-671
21. Szulman A.E., and Surti U. The syndromes hydatidiform mole II. Morphologic evolution of the complete and partial mole. Am. J. Obstet. Gynecol. 132 (1978) 20-27
22. Tuncer Z.S., Vegh G.L., Fulop V., Genest D.R., Mok S.C., and Berkowitz R.S. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol. Oncol. 77 3 (2000) 389-393
23. Xuan Y.H., Choi Y.L., Shin Y.K., et al. Expression of TGF-β signaling proteins in normal placenta and gestational trophoblastic disease. Histol. Histopathol. 22 (2007) 227-234
24. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res. 59 22 (1999) 5830-5835